Insights from 2023 SABCS


 

SABCS 2023 Insights: "APHINITY Trial - The Benefit of Adjuvant Pertuzumab & Trastuzumab According to Estrogen Receptor and HER2 Expression"

275 views
December 13, 2023
0 Comments
Login to view comments. Click here to Login
Videos